Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-14-015608)

Filing Details

Accession Number:: 0001179110-14-015608
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-10-20 18:16:49
Reporting Period:: 2014-10-17

Filing Date:: 2014-10-20
Accepted Time:: 2014-10-20 18:16:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1274057	Hospira Inc	HSP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1372882	E Thomas Werner	C/O Hospira, Inc. 275 North Field Drive Lake Forest IL 60045	Svp, Finance & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-10-17	10,000	$43.18	64,614	No	4	M	Direct
Common Stock	Disposition	2014-10-17	10,000	$50.04	54,614	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Disposition	2014-10-17	10,000	$0.00	10,000	$43.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,566		2015-03-05	No	4	M	Direct

Footnotes

Exercise of derivative security exempted pursuant to Rule 16b-3.
The stock options vest in three equal annual installments on March 6, 2009, 2010, and 2011. The exercise price of $43.18 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on March 5, 2015.